What Does the Street Think About Boston Scientific Corporation (BSX)?

Boston Scientific Corporation (NYSE:BSX) is one of the best strong buy healthcare stocks to invest in. Boston Scientific Corporation (NYSE:BSX) announced on February 23 the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026.

The company also received several rating updates following its fiscal Q4 and full-year earnings release, with BTIG reaffirming a Buy rating on the stock with a price target of $110 on February 20. In addition, Canaccord cut the price target on Boston Scientific Corporation (NYSE:BSX) to $109 from $112 on February 17, maintaining a Buy rating on the shares and telling investors that it updated its model and estimates to reflect the business organizational changes. The firm also updated its estimates to take into account management commentary during and after the earnings call.

Boston Scientific Corporation (NYSE:BSX) announced its fiscal Q4 and full year 2025 earnings on February 4, reporting that it generated net sales of $5.286 billion during fiscal Q4, reflecting a 15.9% growth on a reported basis, 14.3% growth on an operational basis, and 12.7% growth on an organic basis, all compared to the prior year period. For the full year 2025, Boston Scientific Corporation (NYSE:BSX) generated net sales of $20.074 billion, up 19.9% on a reported basis, 19.2% on an operational basis, and 15.8% on an organic basis.

Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.

While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.